Edgard da Veiga Lion Neto is a clinical researcher and medical manager with over 25 years of experience in the pharmaceutical industry. He has worked with many major pharmaceutical companies, including Novartis, Sanofi, Boehringer Ingelheim, and Pfizer. His experience includes managing clinical trials, developing marketing strategies, training sales teams, and providing scientific and regulatory support. He has advanced degrees in medicine, business administration, and legal medicine.

1. Edgard da Veiga Lion Neto, MD; MBA
Clinical Research Clinical Research Clinical Research Clinical Research
Rua Açatunga, 149
Campo Belo, São Paulo – SP - 04612-050
Tel (011) 5533-6201 / Cel.: (011) 99342-9036
edgard.lion@uol.com.br
Professional Profile
Clinical Clinical research
· Medicine College of the University of São Paulo (FMUSP).
· Medical Residency in Surgery at the Clinics Hospital of the FMUSP.
· M. B. A. in Marketing and Communication at ESPM
· Industrial Marketing at Wharton School of the University of Pennsylvania, USA
· Legal Medicine and Expert Testimony specialist at University of São Paulo
· Clinical science proficiency by the FMGEMS - USA
· Experience in development and managing of IITs, clinical trials phase III and IV with GCP standards.
· Years of experience with Health Authorities (ANVISA, Min. of Health) focusing new product registration and
demands solving.
· Years of knowledge in support and managing of ethical marketing for mass and specialty products.
· Active participation in multitask multifunctional international work groups with Global Medical Marketing teams.
· Years of practice in the development and managing of product Advisory Boards, support to continuous medical
education, and support to patient associations.
· Experience in sales force, medical doctors and scientific medical liaisons training towards products detailing.
· Experience as a MSL and in co-managing MSLs.
· Fluent english
Languages
· English: fluent
· Spanish: basic
· French: basic
PROFISSIONAL HISTORY
Clinical Research, clinical research
Hypermarcas – Respiratory care – August 2014
Main contributions:
· Technical support to Marketing on all promotional activities with respiratory drugs for asthma and COPD according
to company compliance HA rules.
· Technical and scientific support for marketing strategies implementation.
· Revision of package inserts and scientific support for DRA and Customer Services department.

2. · Training of the sales force in all technical and clinical details of the drugs under my responsibility and their direct
competition.
· Translating medical knowledge into support and development strategy for the products within the respiratory line.
· Revision and approval of all promotional aids.
· Technical/scientific support for revision and approval of promotional aids and strategic revision of medical
literature searching for product competitive advantages in product promotion.
· Training and development of sales force towards product detailing and competitors.
· .Transformation of medical/scientific data on published articles into useful tools for promotion of respiratory
products and differentiation of the competition.
· Content development for scientific symposia and other scientific meeting.
· Package insert and other regulatory documentation revision.
· Identification of medical topics of interest for the medical community focusing the development of medical Science
programs including advisory boards.
Sanofi – MSL Oncology – May 2013
Report: Group Medical Manager
Main contributions:
· Technical detailing of clinical trials and clinical characteristics of therapeutic agents (chemotherapy and immune
biologic drugs) designed for solid tumors (Prostate and Colon).
· Scientific relationship with top KOLs, KDM and ROLs in hospitals and clinics.
· Training of technical sales consultants.
· Scientific relationship with medical societies.
· Developing of clinical trials and IST/IIT trials with KOLs.
· Scientific discussion of key messages with KOLs, KDMs and ROLs on chemotherapy and immune biologic drugs
for Prostate and Colon cancer.
· Extensive participation on international meeting and congresses.
Boehringer-Ingelheim – Neurology, Urology e Antibiotics – March 2013
Report : Chief Scientific Oficer
Main contributions:
· Technical support to Marketing on all promotional activities with drugs for Parkinson Disease, Prostate Benign
Hyperplasia and antibiotics.
· Technical support for regulatory affairs concerning new products registration and HA demands solving.
· Training of the sales force in all technical and clinical details of the drugs under my responsibility and their direct
competition.
· Coordination of technical translations.
· Technical and scientific support for marketing strategies implementation.
· Revision of package inserts and scientific support for DRA and Customer Services department.
· Technical and scientific support for all promotional activities of the products under my responsibility.
Novartis –Ophthalmology, Mature products and OCT– Jan 2004 / Jul 2012
Report : Chief Scientific Officer
Main contributions:
Strategic support to the Specialty Business Unit (Ophthalmology) and Mature Products:
· Development and implementation of clinical research projects (compassionate use, IIT and phase III /
IV) with immune biological products.
· Execution of the medical publication plan through educational support to independent studies (IITs) in
line with global strategies.
· Scientific consulting for corporate affairs and public relations with Health Authorities, Ministry of Health
and patient associations.
· Technical/scientific support for revision and approval of promotional aids and strategic revision of
medical literature searching for product competitive advantages in product promotion.

3. · Technical/scientific support to continuing medical education, workshops, satellite symposia and other
medical events.
· Revision and approval of promotional material, strategic revision of medical literature in order to localize
technical details to differentiate the company products.
· Technical support for implementation of marketing strategies with immune biologic and mature products.
· Medical Advisor for LatAm mature products (three years in the position).
· Technical support and scientific identification of new business (BD&L) looking for joint ventures in
product development and partnetships.Direct involvement in scientific consulting corporate affairs with
opinion leaders and patient associations.
· Training and development of sales force and scientific consulting force (MSLs) towards product detailing
and competitors.
· Co-managing of MSLs.
· Training of opinion leaders.
· Scientific Strategic and operational support for DRA and Market Access.
· Active participation on national and international events.
· Medical manager for Antiinflamatory/analgesic, Central Nervous System, Cardiology, Dermatology,
Ophthalmology and Mature Products
· MSL for Cardiology, Rheumatology and Orthopedy.
Aché Laboratórios – Abr 2001 / Out 2003
Clinical research, clinical research, Clinical research, Clinical Research
Report : Executive director of Marketing and sales
Main contributions:
· Supervision of five medical managers, one pharmacovigilance manager and one clinical research manager.
· Scientific support for marketing strategy implementation.
· Creation of the pharmacovigilance department.
· Strategic development of clinical research projects, identifications of investigators and research centers.
· Strategic and operational support for DRA and Market Access.
· Support for marketing and corporate public relations strategies.
· Technical support and scientific identification of new business (BD&L) looking for joint ventures in product
development and partnerships together with McKinsey Management Consulting Firm (over 1,000 new
molecules and SKUs overseen).
· Technical/scientific support for licensing in of new molecules and development of combination of molecules
as new products including synthetic and phytomedications.
· Active participation with HA discussions and negotiations.
· Active participation on national scientific events.
Searle Monsanto – Jan 1999 / Dez 2000
Clinical research, clinical research, Clinical research, Clinical Research
Report : Chief Clinical Scientific Officer LatAm/Asia-Pacific
Main contributions :
· Direct participation on scientific consulting, public relations, and training of opinion leaders.
· Technical support for the launching of the first COXIB in the market (Celecoxib).
· Training Medical leader for the COXIB products in LatAm.
· Technical support for the marketing area in promotional activities.
· Sales force training and development.
· Clinical research development, protocol writing, CRFs and diaries writing.
· Identification of investigators and clinical research centers.
· Implementation and conduction of phase IV clinical trials.
· Strategic and operational support for DRA.
· Training and development of opinion leaders.
· Active participation on national and international scientific events.
Pfizer – Abr 1997 / Dez 1998
Clinical research, clinical research, Clinical research, Clinical Research
Report : Clinical Scientific Officer
Main contributions :

4. · Scientific and operational support for marketing promotional activities.
· Development and implementation of Central Nervous System clinical research projects (phase III / IV).
· Training and development of sales force.
· Coordination of clinical research associates.
· Coordination of scientific translations.
· Protocol, CRFs and diaries development.
· Identification of investigators and clinical research centers.
Schering - Plough – Abr 1996 / Abr 1997
Clinical research, clinical research, Clinical research, Clinical Research
Report : Chief Scientific Officer
Main contributions :
· Scientific and operational support for marketing promotional activities.
· Training and development of sales force.
· Strategic and operational support for DRA.
· Protocol, CRFs and diaries development.
· Technical support and scientific identification of new business (BD&L) looking for joint ventures in product
development and partnerships.
· Development and implementation of clinical research projects (phase III / IV).
· Identification of investigators and clinical research centers.
· Active participation on national scientific events.
Sul América Aetna Insurance – Jan 1995 / Dez 1996
Report : Medical Superintendent
Main contributions :
· Teams supervision:
- Five local medical analysts for assessment of personal and company health providers.
- Twenty five medical audits at national level.
- Technical support to reimbursement and debt department.
· Technical support to the vice presidency and legal department.
· Active participation on new product development.
· Training of medical analysts.
GRADUATION
· Eletrotechnics at Federal School of São Paulo - 1981
· Medicine college of the University of São Paulo - 1988
· Medical Residency in Surgery at the Clinics Hospital - 1992
· Medical proficiency by the Educational Commission of Foreign Medical Graduates (FMGEMS), USA (1992)
· Specialization on Hospital administration (CEDAS) – São Camilo - 1994
· Specialization on Marketing administration (FEA-USP) – 1995
· 100 IMS pharmaceutic marketing - 1996
· Field Monitoring and Medical Orientation Seminar at Pfizer, Inc, New York.; Product Management Development
at Pfizer (RJ) – 1997
· Industrial Marketing at Wharton School of the University of Pennsylvania, USA.;
· Social Styles at Monsanto in Toronto, Canadá – 1999.
· Statistical methods in clinical research (SBPPC) – 2001.
· Biostatistics UNIFESP – 2002
· Certification on ICH-GCP Clinical Research by the Novartis International Clinical Research Organization - 2006
· M.B.A in Marketing and Communication - ESPM – 2006
· Legal Medicine and Expert Testimony specialization – University of Sao Paulo - 2013

5. CLINICAL EXPERIENCE
· Private office – 1990 - 1995
· HMO medical surgeon - Grupo Eluma – 1992 - 1995
· Emergency medicine - SAMEB – 1994 - 1997
SOCIETIES
· Member of the Sociedade Brasileira de Medicina Farmacêutica (SBMF)
· Coordinator of the IT committee - SBMF
· First Secretary - SBMF (2006-2007)
TITLES
· Proficiency in Medicine by the Educational Commission of Foreign Medical Graduates (FMGEMS), USA (1992)
· International Clinical Research / ICH-GCP Compliance by Novartis International Clinical Research Organization
(ICRO)
PUBLICATIONS
Avaliaçäo do DNA pela citofotometria nos tumores papiliferos da tireoide / DNA evaluation by cytophotometry in papillary
thyroid tumour
Rev. Col. Bras. Cir; 17(5):90-3, set-out. 1990.
RECOMENDATIONS
· Ricardo Maykot, MBA (Marketing and sales executive Director Novartis): Edgard has a robust background in
several therapeutic areas, a good sense of medical-marketing strategies which enable him for various
positions in the pharma industry. Extremely reliable, good player working in teams, he conquered my respect
and trust."
· Leandro Mattos Boer Martins, MD, PhD (Medical Specialist Novartis USA): "Edgar is an experienced,
proactive and tireless contributor who makes great addition to any medical team. He always completes his
assignments on time with excellence and is committed to the team in times of very difficult challenges and
corporative overturns. I would highly recommend him for any medical position in the pharmaceutical
industry."
· Felipe Pinho, MD, PhD (Diretor Médico Instituto do Sono - UNIFESP): "I worked with Edgard in Schering-
Plough. He has the two most important skills to work in a pharmaceutical company: high level technical
knowledge and impeccable ethical values."
· - Alvaro Cavalcante (Gerente de Produtos Novartis): "Edgard é um profissional multifuncional, com sólida
experiência em diversas áreas terapêuticas. Tem perfil "hands on" e rapidamente se adapta a estrutura de
negócio."
· Leonardo Mallmann (Senior Marketing Manager for HIV - Virology at Merck): "Dr. Edgard is a detail-oriented
medical manager who doesn´t lose sight of the strategic objective and is focused on growing the business.
· Julio Madi (Sr. Medical Adviser at Hypermarcas S/A): “Edgard is a well-known medical manager at the
pharma industry. He is an "easy to work with" person who can challenge you in a positive and result-oriented
way. Always looking ahead, he is nice as a medical-marketing team player in different therapeutic areas.”

6. · David Lago (Legal Director Safra Bank, former Senior Legal Manager Novartis): "Edgard is an outstanding
professional, highly competent and committed, with wide experience as Medical Manager. He has very good
relationship with his colleagues and focus on the company’s targets."
· Renata Berardocco, PharmD (Project Director & Head of Brazil at Covance): "Edgard is a very good
professional and results oriented. He is a pleasant person to work with and a good team player."
REFERENCES
· Silvia Sfeir (Director of Market Access, Public Commercial Sales, Health Economics, BD&L and New
Products Planning Novartis): Silvia.sfeir@novartis.com Phone +55 11 55327122 Cell: 99656-1036.
· Patricia Pigola, PharmD (Director of Regulatory Affairs da Novartis): patricia.pigola@novartis.com Phone +
55 11 55327590
· João Navarro, MD, MBA (Sanofi LatAm Medical Manager), joao.navarro@sanofi.com.br, phone: 55 11
37596726
· Felipe Dos Santos Pinho, MD, PhD (Instituto do Sono - UNIFESP ): f.spinho@uol.com.br ou
felipe.pinho@ems.com.br Phone 55 19 92127964
· Ricardo Maykot (Executive Director, Commercial Operations, Innovation and BU support, Novartis):
ricardo.maykot@novartis.com Phone +55 11 5532-7713
· Leandro Martins, MD, PhD (Medical Specialist Novartis New Jersey, NJ, USA):
leandro.martins@novartis.com Phone +1 862 7783959

7. · David Lago (Legal Director Safra Bank, former Senior Legal Manager Novartis): "Edgard is an outstanding
professional, highly competent and committed, with wide experience as Medical Manager. He has very good
relationship with his colleagues and focus on the company’s targets."
· Renata Berardocco, PharmD (Project Director & Head of Brazil at Covance): "Edgard is a very good
professional and results oriented. He is a pleasant person to work with and a good team player."
REFERENCES
· Silvia Sfeir (Director of Market Access, Public Commercial Sales, Health Economics, BD&L and New
Products Planning Novartis): Silvia.sfeir@novartis.com Phone +55 11 55327122 Cell: 99656-1036.
· Patricia Pigola, PharmD (Director of Regulatory Affairs da Novartis): patricia.pigola@novartis.com Phone +
55 11 55327590
· João Navarro, MD, MBA (Sanofi LatAm Medical Manager), joao.navarro@sanofi.com.br, phone: 55 11
37596726
· Felipe Dos Santos Pinho, MD, PhD (Instituto do Sono - UNIFESP ): f.spinho@uol.com.br ou
felipe.pinho@ems.com.br Phone 55 19 92127964
· Ricardo Maykot (Executive Director, Commercial Operations, Innovation and BU support, Novartis):
ricardo.maykot@novartis.com Phone +55 11 5532-7713
· Leandro Martins, MD, PhD (Medical Specialist Novartis New Jersey, NJ, USA):
leandro.martins@novartis.com Phone +1 862 7783959